Is the Food & Drug Administration on a path towards 100% user fee funding? It just might be, says Alan Goldhammer.
Not just FDA, actually: given the overall budget climate, Goldhammer said during the Food & Drug Law Institute annual meeting...
FDA and User Fees: Time to Give 100%?
Listen to this article
The share of drug reviews funded by industry fees has climbed steadily over two decades, and is going to jump again once generic drug and biosimilar fees become reality. It may be time to move to an all user fee model for drug reviews.
Learn what's happening at the US FDA. On the go.
More from Archive
- • By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
- • By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
More from Pink Sheet
- • By
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
- • By
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.
- • By
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
